SSA
KURA icon

Schonfeld Strategic Advisors’s Kura Oncology KURA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-54,253
Closed -$664K – 2336
2023
Q1 		$664K Buy
+54,253
New +$677K 0.01% 1084
2021
Q4 		– Sell
-45,500
Closed -$852K – 2351
2021
Q3 		$852K Sell
45,500
-43,500
-49% -$820K 0.01% 1020
2021
Q2 		$1.85M Buy
89,000
+4,298
+5% +$107K 0.02% 738
2021
Q1 		$2.4M Buy
84,702
+64,464
+319% +$2.04M 0.03% 617
2020
Q4 		$660K Sell
20,238
-6,479
-24% -$228K 0.01% 947
2020
Q3 		$818K Buy
+26,717
New +$590K 0.02% 756
2018
Q4 		– Sell
-266,300
Closed -$4.66M – 1160
2018
Q3 		$4.66M Buy
266,300
+182,400
+217% +$3.5M 0.21% 144
2018
Q2 		$1.53M Sell
83,900
-1,676
-2% -$28.4K 0.08% 319
2018
Q1 		$1.6M Buy
+85,576
New +$1.67M 0.12% 238

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Schonfeld Strategic Advisors's KURA Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 54,253 shares — an estimated $664K sold.

Schonfeld Strategic Advisors first reported a position in KURA in Q1 2018 and held it in 9 quarters. The position peaked at $4.66M in Q3 2018. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • Schonfeld Strategic Advisors reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 54,253 Kura Oncology shares in Q2 2023, an estimated $664K.
  • Schonfeld Strategic Advisors first reported a position in Kura Oncology in Q1 2018 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Kura Oncology position peaked at $4.66M in Q3 2018.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.